USANA Health Sciences, Inc. (USNA) financial statements and ratios from SEC XBRL: revenue $925.26M (TTM), net margin 1.2%, revenue growth -5.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $925.26M |
| Net Margin | 1.2% |
| Revenue Growth (YoY) | -5.3% |
| EPS Growth (YoY) | -323.1% |
| FCF Growth (YoY) | 180.4% |
| EV / EBITDA | 2.5 |
| Price / Book | 0.48 |
| Price / Sales | 0.27 |
| FCF Yield | 6.4% |
| DCF Value (model) | $23.55 |
| DCF Upside vs Price | 73.7% |
| Altman Z-Score | 3.26 (safe) |
| Sector P/E (Healthcare) | 21.7 |
USNA overview · USNA earnings · USNA KPIs · USNA investor relations · USNA ownership · USNA peers · USNA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.